Patent ductus arteriosus primary prevention

Revision as of 17:24, 2 November 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Patent Ductus Arteriosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Patent Ductus Arteriosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Treatment

Medical Therapy

Preterm Infants
Term and Older Children

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Patent ductus arteriosus primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Patent ductus arteriosus primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Patent ductus arteriosus primary prevention

CDC on Patent ductus arteriosus primary prevention

Patent ductus arteriosus primary prevention in the news

Blogs on Patent ductus arteriosus primary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Patent ductus arteriosus primary prevention

Overview

The development of a fetal heart starts during the first trimester of pregnancy. Thus, many a times the fetal heart has already developed, by the time the female becomes aware of being pregnant. There are some risk factors that if avoided before and during pregnancy can decrease the occurrence of congenital heart diseases.

Prevention

General

The development of a fetal heart starts during the first trimester of pregnancy. Thus, many a times the fetal heart has already developed, by the time the female becomes aware of being pregnant. Some steps taken before and during pregnancy that can help in preventing the congenital heart diseases are as follow-

  • All females planning for pregnancy should start taking folate (400micrograms/day). This is so because, the birth defects occur most commonly during first trimester of pregnancy even before the female is aware of being pregnant.
  • Avoid medications like lithium, anti-acne drugs (retinoic acid) and some anti-epileptic drugs.
  • Ensuring the female has proper immunity against Rubella (before getting pregnant).
  • Ensure proper and complete treatment of upper respiratory tract infections.
  • Avoid viral infections
  • Avoid intravenous drug abuse
  • Avoid alcohol
  • Avoid strong chemicals (solvents)
  • Avoid X-rays

Specific

  • Women with some diseases like diabetes, seizures etc should consult their physicians before and during pregnancy for special management strategies for these diseases to prevent the occurrence of congenital heart diseases.
  • Females with phenylketonuria may need to follow a special phenylketoneuric diet before pregnancy and during the first trimester.
  • Genetic counselling can be offered to parents who have previous history of a child with birth defect or with family history.

References

Template:WH Template:WS